GlassScriptPhysician profile
William G Cumbie
NPI 1043709553
$5,829.36
in general payments reported to CMS, 2019-2025
13 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.59 · 2022: $145 · 2023: $3,379 · 2024: $1,619 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,111 · Travel and Lodging: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,110.91 |
| Travel and Lodging | $1,555.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $2,395.51 | 2023 | Mpo Medial Pivot Knee, Mpo Hip System |
| Stryker Corporation | $1,172.21 | 2024-2025 | Mako, Triathlon |
| Linkbio Corp | $510.99 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $501.46 | 2023-2024 | Oss Orthopedic Salvage System, Persona, Avenir |
| Smith+Nephew, INC. | $380.64 | 2023-2024 | Real Intelligence, Redapt, Legion Revision |
| Medacta USA, INC. | $260.44 | 2024 | |
| Medical Device Business Services, INC. | $228.81 | 2023-2025 | Attune |
| Davol INC. | $145.08 | 2022 | |
| Depuy Synthes Sales INC. | $127.04 | 2023-2025 | Na, Monovisc |
| Vertex Pharmaceuticals Incorporated | $34.89 | 2025 | |
| Bioventus LLC | $30.96 | 2025 | Gelsyn-3 |
| Medtronic, INC. | $23.74 | 2025 | Venaseal |
| Rock Medical Orthopedics, INC. | $17.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cumbie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.